HomeCOPN • SWX
add
Cosmo Pharmaceuticals NV
Previous close
CHF 72.10
Day range
CHF 71.90 - CHF 74.10
Year range
CHF 33.70 - CHF 76.00
Market cap
1.26B CHF
Avg Volume
26.35K
P/E ratio
1,038.64
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 26.53M | -12.41% |
Operating expense | 13.74M | 58.33% |
Net income | -169.50K | -103.62% |
Net profit margin | -0.64 | -104.15% |
Earnings per share | — | — |
EBITDA | 5.87M | -55.27% |
Effective tax rate | 103.53% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 50.28M | -79.13% |
Total assets | 553.98M | -27.07% |
Total liabilities | 120.35M | -59.32% |
Total equity | 433.63M | — |
Shares outstanding | 16.05M | — |
Price to book | 2.71 | — |
Return on assets | 1.15% | — |
Return on capital | 1.46% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -169.50K | -103.62% |
Cash from operations | 9.07M | -12.19% |
Cash from investing | 48.27M | 400.72% |
Cash from financing | -91.63M | -1,197.44% |
Net change in cash | -34.22M | -112.54% |
Free cash flow | 661.50K | -89.85% |
About
Founded
1997
Website
Employees
325